Tue, 15 May 2012 15:53:29 +0200

DiaGenic awarded research grant of NOK 7.8 million for further development of DiaGenics tests for early detection of Alzheimer’s disease

Wed, 09 May 2012 08:30:00 +0200

Report from first quarter 2012

Tue, 08 May 2012 13:00:00 +0200

DiaGenic has been granted world-wide trademarks for its key brands ADtect®, BCtect®, PDtect® and MCItect®

Oslo – May 8th 2012: DiaGenic ASA [OSL:DIAG] have received grants of world-wide trademark for key brand names in the DiaGenic portfolio: ADtect®, MCItect®, PDtect® and BCtect®. Trademark protection adds to building a strong portfolio of intellectual properties (IP) for product commercialization.

Tue, 08 May 2012 09:40:09 +0200

DiaGenic reports completion of data collection and genetic analyses in a unique study on familial Parkinson’s disease

Oslo – May 8th 2012 (DiaGenic ASA [OSL:DIAG]): DiaGenic today reports on the finalization of data collection and database lock of a blinded study in a Norwegian cohort of 80 patients with familial Parkinson’s disease (PD). The majority of these patients are carrying a mutation in the parkin 8 gene (also called LRRK2) that significantly increases the risk of developing PD. Patients recruited from St Olavs University Hospital under the lead of Principal Investigator Professor Jan Aasly are all LRRK2 mutation carriers with or without the disease or healthy relatives. Unblinding of the study is set to the May 16th and analysis and reporting is expected to be completed during summer 2012.

Wed, 02 May 2012 15:00:00 +0200

DiaGenic awarded for best article in 2011

Wed, 02 May 2012 11:36:28 +0200

Presentation of results for first quarter 2012

Thu, 26 Apr 2012 17:31:59 +0200

New date for Annual General Meeting

Wed, 18 Apr 2012 18:10:07 +0200

NOTIFICATION OF TRADE AMONG PRIMARY INSIDER

Tue, 17 Apr 2012 08:30:00 +0200

CEO Erik Christensen resigns from his position

Mon, 02 Apr 2012 11:30:37 +0200

DiaGenic ASA: Annual overview